NPA identified several key targets, including EGFR, PTGS2, ERBB2, IL10, PPARG, etc., that are intimately linked to the initiation and progression of HCC (Lin et al., 2024). The gene discussed is PTGS2; the disease is hepatocellular carcinoma.